Reference | Study | Key findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Typea | species | bacterial target | antimicrobial drug | administration route | study outcomes related to antimicrobial resistance | study design | susceptibility testing | controls | ||
Grade level: Controlled trial | ||||||||||
[46] | RCT | broiler chicken | Campylobacter experimental infection with 5 susceptible strains on day 16 or 24 of life | fluoroquinolones enrofloxacin, sarafloxacin, ciprofloxacin; treated for 5Â days, starting on day 30 of life | drinking water | emergence of resistance | 2 groups; 25 or 50 chicks per group (half treated) | Phenotypic agar dilution | negative controls | resistance emerged rapidly in isolates from treated birds and, for birds treated with enrofloxacin, resistance was retained throughout the sampling period; resistance remained low in untreated controls throughout the study |
[47] | RCT | pigs | Salmonella Typhimurium DT104; native E. coli population monitored; experimental infection with 5 strains isolated from apparently healthy pigs (pentaresistant phenotype) | aureomycin, standard or subtherapeutic dose, treated for 7Â days starting 48Â h after inoculation | feed | emergence of resistance | 3 groups; 6 pigs per group | Phenotypic agar dilution | negative controls | resistance emerged in native E. coli populations from treated animals and increased resistance persisted for 2Â weeks after treatment; treated pigs shed higher numbers of Salmonella Typhimurium DT104 than untreated pigs. |
[48] | RCT | pigs | Salmonella Typhimurium; native E. coli population; experimental challenge of piglets 2Â days after weaning | aparamycin in different dosing schemes, in some cases followed by sulfamethazine and carbadox or gentamicin and neomycin; treatment initiated 7Â days after infection, for 14Â days | feed or drinking water | emergence of resistance | 2 trials; 6 groups of 8 pigs each | Phenotypic dilution test | negative controls | resistance of Salmonella isolates was not impacted by treatment regimen; resistance emerged in native E. coli populations and was effected by treatment regimen; use of similar antibiotics in rotation resulted in greater resistance than if dissimilar antibiotics were used |
[49] | CT | broiler chicken | Campylobacter; experimental infection with susceptible strain on day 19 of life | fluoroquinolones: enrofloxacin or flumequine in different concentrations; treated for 4Â days, beginning 7Â days after infection (or on day 1 of the experiment for one group) | drinking water | emergence of resistance | 8 groups; 15 chicks per group | Phenotypic disc diffusion | negative controls | resistance emerged in Campylobacter isolates from enrofloxacin treated birds (isolates from all other groups remained susceptible) |
[50] | CT | beef cattle | Campylobacter; naturally occurring bacterial populations | chlortetracycline with or without sulfamethazine; virginiamycin; monensin; or tylosin; treated for 56Â days, starting 18Â days after arrival at feedlot; antimicrobials removed for 91Â days, reintroduced for 42Â days | feed | emergence of resistance | 30 groups; 10 steers per group | Phenotypic agar dilution | negative controls | administration of antimicrobial drugs increased the carriage rate for resistant isolates, but results differed by antimicrobial drug and Campylobacter species |
[51] | RCT | pigs | Salmonella Typhimurium with nalidixic acid resistance; native E. coli population; experimental challenge of piglets (from treated or untreated sows) | oxytetracycline, aparamycin; sows treated prior to farrowing | feed | emergence of resistance (in piglets after treatment of sows) | 3 groups of pigs | Phenotypic dilution test Genotypic PCR-based | negative controls | Exposure of sows to oxytetracycline associated with increased resistance in bacterial isolates from pigs |
[52] | RCT | Pigs | Campylobacter; naturally occurring populations | enrofloxacin; treated with standard therapeutic dose for 5Â days | per os | emergence of resistance | 2 groups of pigs; 6 pigs per group | Phenotypic agar dilution | negative controls | exposure to enrofloxacin resulted in Campylobacter isolates resistant to nalidixic acid and ciprofloxacin (no quinolone resistance detected prior to antibiotic exposure); resistant isolates detected for up to 35Â days |
[53] | RCT | Pigs | Salmonella Typhimurium; experimental challenge with marked strain containing nalidixic acid resistance marker | ceftiofur, aparamycin, or carbadox, followed by oxytetracycline; Treated starting 2 days post inoculation | feed (i.m. for ceftiofur) | emergence of resistance | 4 groups of pigs; 12 pigs per group | Phenotypic Disc diffusion | negative controls | frequency of antimicrobial resistance varied over time – resistance was lowest on day 4 post inoculation but increased steadily afterwards and was highest on the last day of sampling; continued increase of select antimicrobial resistance after exposure was discontinued |
Grade level: observational study | ||||||||||
[54] | Cohort period: 2000–2001 | dairy cattle | Salmonella | various used on conventional farms | n/a | antimicrobial resistance levels | 95 farms: 26 organic and 69 conventional | Phenotypic broth dilution | organic vs. conventional | results differed by antibiotic; for most antimicrobial drugs, resistance levels were not significantly different; resistance to streptomycin and sulfamethoxazole was greater on conventional farms. |
[55] | CS | dairy cattle | Campylobacter | various used on conventional farms | n/a | antimicrobial resistance levels | 60 farms: 30 organic and 30 neighboring conventional | Phenotypic disk diffusion | organic vs. conventional | no statistically significant difference in resistance rates for organic vs. neighboring conventional dairy herds |
[56] | CS | broiler chicken and turkey | Campylobacter | various used on conventional farms (gentamicin, lincomycin, bacitracin, virginiamycin, etc.) | feed and water | antimicrobial resistance levels | 30 farms: 10 organic, 20 conventional | Phenotypic agar dilution | organic vs. conventional | antimicrobial resistance rates were significantly higher in isolates from conventional than organic farms, and conventional isolates were significantly more likely to be multi-drug resistant; resistance levels varied across antimicrobial drugs |
Grade level: other | ||||||||||
[57] | Longitudinal study | broiler chicken | Campylobacter | fluoroquinolones; difloxacin or enroflaxcin; treatment for 5 days to treat clinically relevant infection; bacterial samples taken before, during and after treatment of flocks | drinking water | prevalence of antimicrobial resistance | 5 commercial flocks | Phenotypic agar dilution Genotypic PCR-based | resistance before, during and after treatment | prevalence of resistant strains increased during treatment and remained elevated after treatment |
[58] | bacterial samples at slaughter | broiler chicken | Campylobacter | various used on conventional farms | various | prevalence of antimicrobial resistance at slaughter | n = 600 ceacal samples from chicken | Phenotypic dilution method | resistance levels at slaughter as a function of production type and antimicrobial use history | antimicrobial resistance levels differed significantly by production type and antimicrobial administration history |
[59] | bacterial samples of retail meats | Chicken meat | Campylobacter | fluoroquinolone | presumably water | Prevalence of resistance | 5 producers, meats sampled at retail for 20 consecutive weeks in 2004 and 15 consecutive weeks in 2006 | Phenotypic | NAE vs. conventional | No statistically significant difference in fluoroquinolone resistance levels after use was reportedly discontinued (no sample collection or validation at the farm or producer level) |
[60] | bacterial samples | chicken and turkey meat; healthy human volunteers | Enterococci; VanA-type vancomycin resistant (VRE) | avoparcin use for growth promotion phased out during study period | various | levels of VRE prevalence | convenience samples | N/A | VRE carrier rates before and after the ban | VRE detection in poultry meat and intestinal bacteria of healthy volunteers decreased after the ban |
[61] | bacterial samples | humans and poultry products | Campylobacter | fluroquinolones | n/a | prevalence of resistance | convenience sample, collected from 1982 to 1989 | Phenotypic disk diffusion | prevalence of resistance over time | prevalence of quinolone resistance increased from 0 to 14% in poultry products and from 0 to 11% in human samples |
[62] | bacterial samples at slaughter | broiler chicken | Campylobacter | various used on conventional farms; 1992–1996 time period falls before ban for antibiotic growth promoters, 2001–2002 period does not | various | prevalence of antimicrobial resistance at slaughter | 22 flocks; 10 chickens per flock | Phenotypic agar dilution | resistance levels at slaughter as a function of production type (free-range or standard) and study period | antimicrobial resistance was more likely in isolates from standard than free-range chicken, differed by Campylobacter strain, and for many antimicrobial drugs and strains resistance increased over time |
[63] | correlation study | isolates from chicken meat and humans | Salmonella Heidelberg, ceftiofur resistant commensal E. coli | 2003–2008 | n/a | prevalence of ceftiofur-resistance in bacterial isolates from chicken meat and human cases | Correlation across provinces and time periods | Phenotypic broth dilution | Resistance levels before, during, and after a voluntary discontinuation of ceftiofur use in hatcheries in Quebec | Statistically significant correlation between prevalence of ceftiofur-resistant Salmonella Heidelberg on retail chicken and human infections; in Quebec, levels of ceftiofur use in hatcheries during study period seemed correlated with ceftiofur resistance in chicken Salmonella and E. coli isolates. |
[64] | Longitudinal study | pigs | Enterococcus faecium | tylosin; resistance to erythromycin, spiramycin, clindamycin, penicillin, tetracycline, chloramphenicol, streptomycin, gentamycin | feed | prevalence of antimicrobial resistance | 16 farms; 13 farms were examined again 183 to 287Â days later | Phenotypic disk diffusion | resistance before and after the ban of tylosin as a growth promoter | Resistance to macrolides, lincosamides and tetracyclines decreased after the use of tylosin for growth promotion was banned. |